Guy Goodwin joins COMPASS Pathways as Chief Medical Officer

COMPASS Pathways announces the appointment of eminent psychiatrist, Professor Guy Goodwin, as Chief Medical Officer.

Visit article

Category Press Release

Companies Featured

COMPASS Pathways
COMPASS Pathways is a publicly listed company (NASDAQ) that is developing psilocybin for treatment-resistant depression (TRD) for which it has completed a successful Phase IIb trial. COMPASS is one of the largest psychedelic companies and has received substantial investment from atai.

People Featured

Guy Goodwin
Dr Guy Goodwin is the Chief Medical Officer at COMPASS Pathways and an Emeritus Professor of Psychiatry at the University of Oxford, UK. His research focusses on the neurobiology and treatment of mood disorders, such as bipolar depression, with a focus on the commercial development of COMP360 psilocybin.